US Stock MarketDetailed Quotes

Aldeyra Therapeutics (ALDX)

Watchlist
  • 4.410
  • +0.170+4.01%
Close Jan 15 16:00 ET
  • 4.430
  • +0.020+0.45%
Pre 08:58 ET
265.32MMarket Cap-6.04P/E (TTM)

Aldeyra Therapeutics (ALDX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
11.96%-7.02M
35.31%-8.56M
-25.04%-12.47M
-42.48%-43.21M
-2,505.25%-12.04M
0.62%-7.97M
1.00%-13.22M
-5.60%-9.97M
46.46%-30.33M
104.46%500.44K
Net income from continuing operations
49.13%-7.69M
42.03%-9.77M
-22.86%-9.93M
-48.77%-55.85M
-232.61%-15.81M
-84.60%-15.11M
-87.47%-16.85M
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
Depreciation and amortization
1.10%63.68K
1.06%62.28K
0.46%60.91K
-5.01%249.62K
-3.15%64.37K
-3.10%62.99K
-4.21%61.63K
-9.47%60.63K
1.57%262.78K
-0.26%66.47K
Other non cash items
33.85%50.37K
33.85%50.37K
15.49%67.16K
-49.94%177.33K
-37.93%43.92K
-60.78%37.63K
-62.50%37.63K
-33.28%58.15K
6.96%354.19K
-14.51%70.75K
Change In working capital
-140.77%-1.76M
-36.97%1.33M
-40.27%-4.75M
586.64%5.91M
-51.57%2.87M
648.12%4.32M
134.60%2.11M
-283.85%-3.39M
125.00%861.18K
562.65%5.92M
-Change in prepaid assets
-96.26%50.15K
-81.62%457.85K
108.88%250.51K
19.09%2.07M
194.89%1.06M
1,974.10%1.34M
405.82%2.49M
-175.57%-2.82M
146.14%1.73M
56.70%-1.11M
-Change in payables and accrued expense
-160.81%-1.81M
331.93%874.4K
-784.97%-5M
155.97%3.85M
75.96%1.81M
515.70%2.98M
92.88%-377.02K
70.12%-565.05K
-2,273.11%-6.87M
-20.23%1.03M
-Change in other working capital
----
----
----
----
----
----
----
----
--6M
----
Cash from discontinued investing activities
Operating cash flow
11.96%-7.02M
35.31%-8.56M
-25.04%-12.47M
-42.48%-43.21M
-2,505.25%-12.04M
0.62%-7.97M
1.00%-13.22M
-5.60%-9.97M
46.46%-30.33M
104.46%500.44K
Investing cash flow
Cash flow from continuing investing activities
375.05%25M
96.96%-554.13K
124.00%7.29M
-249.72%-44.92M
-1.56M
5.26M
-18.24M
-201.26%-30.38M
200.15%30M
0
Net investment purchase and sale
375.05%25M
96.96%-554.13K
124.00%7.29M
-249.72%-44.92M
---1.56M
--5.26M
---18.24M
-201.26%-30.38M
200.21%30M
--0
Cash from discontinued investing activities
Investing cash flow
375.05%25M
96.96%-554.13K
124.00%7.29M
-249.72%-44.92M
---1.56M
--5.26M
---18.24M
-201.26%-30.38M
200.15%30M
--0
Financing cash flow
Cash flow from continuing financing activities
161.17%120.75K
0
5,412.67%1M
86.50%-171.42K
100.77%7.78K
37.49%-197.39K
0
-65.39%18.19K
-204.11%-1.27M
-1.01M
Net issuance payments of debt
----
----
----
71.94%-292.5K
----
----
----
----
---1.04M
----
Proceeds from stock option exercised by employees
507.71%120.75K
--0
5,412.67%1M
27.23%388.34K
1,060.33%350.28K
-90.85%19.87K
--0
-65.39%18.19K
-74.98%305.23K
--30.19K
Net other financing activities
----
----
----
49.85%-267.26K
---50K
----
----
----
---532.95K
--0
Cash from discontinued financing activities
Financing cash flow
161.17%120.75K
--0
5,412.67%1M
86.50%-171.42K
100.77%7.78K
37.49%-197.39K
--0
-65.39%18.19K
-204.11%-1.27M
---1.01M
Net cash flow
Beginning cash position
-41.94%41.24M
-50.87%50.35M
-61.82%54.53M
-1.11%142.82M
-52.47%68.12M
-53.17%71.03M
-37.89%102.49M
-1.11%142.82M
-37.15%144.42M
11.41%143.33M
Current changes in cash
722.04%18.1M
71.05%-9.11M
89.64%-4.18M
-5,431.12%-88.3M
-2,555.53%-13.59M
65.11%-2.91M
-135.63%-31.46M
-295.70%-40.33M
98.13%-1.6M
-103.25%-511.87K
End cash Position
-12.89%59.34M
-41.94%41.24M
-50.87%50.35M
-61.82%54.53M
-61.82%54.53M
-52.47%68.12M
-53.17%71.03M
-37.89%102.49M
-1.11%142.82M
-1.11%142.82M
Free cash flow
11.96%-7.02M
35.31%-8.56M
-25.04%-12.47M
-42.48%-43.21M
-2,505.25%-12.04M
0.62%-7.97M
1.00%-13.22M
-5.60%-9.97M
46.47%-30.33M
104.46%500.44K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 11.96%-7.02M35.31%-8.56M-25.04%-12.47M-42.48%-43.21M-2,505.25%-12.04M0.62%-7.97M1.00%-13.22M-5.60%-9.97M46.46%-30.33M104.46%500.44K
Net income from continuing operations 49.13%-7.69M42.03%-9.77M-22.86%-9.93M-48.77%-55.85M-232.61%-15.81M-84.60%-15.11M-87.47%-16.85M48.24%-8.08M39.47%-37.54M63.16%-4.75M
Depreciation and amortization 1.10%63.68K1.06%62.28K0.46%60.91K-5.01%249.62K-3.15%64.37K-3.10%62.99K-4.21%61.63K-9.47%60.63K1.57%262.78K-0.26%66.47K
Other non cash items 33.85%50.37K33.85%50.37K15.49%67.16K-49.94%177.33K-37.93%43.92K-60.78%37.63K-62.50%37.63K-33.28%58.15K6.96%354.19K-14.51%70.75K
Change In working capital -140.77%-1.76M-36.97%1.33M-40.27%-4.75M586.64%5.91M-51.57%2.87M648.12%4.32M134.60%2.11M-283.85%-3.39M125.00%861.18K562.65%5.92M
-Change in prepaid assets -96.26%50.15K-81.62%457.85K108.88%250.51K19.09%2.07M194.89%1.06M1,974.10%1.34M405.82%2.49M-175.57%-2.82M146.14%1.73M56.70%-1.11M
-Change in payables and accrued expense -160.81%-1.81M331.93%874.4K-784.97%-5M155.97%3.85M75.96%1.81M515.70%2.98M92.88%-377.02K70.12%-565.05K-2,273.11%-6.87M-20.23%1.03M
-Change in other working capital ----------------------------------6M----
Cash from discontinued investing activities
Operating cash flow 11.96%-7.02M35.31%-8.56M-25.04%-12.47M-42.48%-43.21M-2,505.25%-12.04M0.62%-7.97M1.00%-13.22M-5.60%-9.97M46.46%-30.33M104.46%500.44K
Investing cash flow
Cash flow from continuing investing activities 375.05%25M96.96%-554.13K124.00%7.29M-249.72%-44.92M-1.56M5.26M-18.24M-201.26%-30.38M200.15%30M0
Net investment purchase and sale 375.05%25M96.96%-554.13K124.00%7.29M-249.72%-44.92M---1.56M--5.26M---18.24M-201.26%-30.38M200.21%30M--0
Cash from discontinued investing activities
Investing cash flow 375.05%25M96.96%-554.13K124.00%7.29M-249.72%-44.92M---1.56M--5.26M---18.24M-201.26%-30.38M200.15%30M--0
Financing cash flow
Cash flow from continuing financing activities 161.17%120.75K05,412.67%1M86.50%-171.42K100.77%7.78K37.49%-197.39K0-65.39%18.19K-204.11%-1.27M-1.01M
Net issuance payments of debt ------------71.94%-292.5K-------------------1.04M----
Proceeds from stock option exercised by employees 507.71%120.75K--05,412.67%1M27.23%388.34K1,060.33%350.28K-90.85%19.87K--0-65.39%18.19K-74.98%305.23K--30.19K
Net other financing activities ------------49.85%-267.26K---50K---------------532.95K--0
Cash from discontinued financing activities
Financing cash flow 161.17%120.75K--05,412.67%1M86.50%-171.42K100.77%7.78K37.49%-197.39K--0-65.39%18.19K-204.11%-1.27M---1.01M
Net cash flow
Beginning cash position -41.94%41.24M-50.87%50.35M-61.82%54.53M-1.11%142.82M-52.47%68.12M-53.17%71.03M-37.89%102.49M-1.11%142.82M-37.15%144.42M11.41%143.33M
Current changes in cash 722.04%18.1M71.05%-9.11M89.64%-4.18M-5,431.12%-88.3M-2,555.53%-13.59M65.11%-2.91M-135.63%-31.46M-295.70%-40.33M98.13%-1.6M-103.25%-511.87K
End cash Position -12.89%59.34M-41.94%41.24M-50.87%50.35M-61.82%54.53M-61.82%54.53M-52.47%68.12M-53.17%71.03M-37.89%102.49M-1.11%142.82M-1.11%142.82M
Free cash flow 11.96%-7.02M35.31%-8.56M-25.04%-12.47M-42.48%-43.21M-2,505.25%-12.04M0.62%-7.97M1.00%-13.22M-5.60%-9.97M46.47%-30.33M104.46%500.44K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More